Solvay Pharma Can't Dodge False Claims Act Whistleblower Claims
The health care marketplace requires the ever-vigilant policing of the Department of Justice and fraud whistleblowers. Using bribery to sell drugs is health care fraud and endangers the public health. It’s even worse when those who are bribed are paid to spread a message that is not approved by the FDA, to use drugs to treat a condition that the FDA has not found safe and effective for use. When those rules are broken, companies deserve every bit of punishment. — Shayne Stevenson
Solvay Pharma Must Face Bribery Claims
Solvay Pharmaceuticals cannot duck whistleblower claims that it bribed Medicaid doctors to prescribe its drugs for unapproved uses, a federal judge ruled.
Two former Solvay managers, John King and Tammy Drummond, sued the company in 2006, alleging it violated the False Claims Act by paying doctors kickbacks in the form of “bogus speaker and research fees, resort weekends, cash payments, or Harley Davidson goods” to prescribe its drugs Aceon, Luvox and AndroGel for uses not approved by the Food and Drug Administration.
Solvay is a Belgian chemical company. Its co-defendant subsidiary, Solvay America, is based in Houston. Another defendant is Solvay Pharmaceuticals, which was a Solvay subsidiary until Abbott Laboratories acquired it in 2009, and spun it off into a new entity called AbbVie Products. Full article »
Solvay Pharmaceuticals cannot duck whistleblower claims that it bribed Medicaid doctors to prescribe its drugs for unapproved uses, a federal judge ruled.
Two former Solvay managers, John King and Tammy Drummond, sued the company in 2006, alleging it violated the False Claims Act by paying doctors kickbacks in the form of “bogus speaker and research fees, resort weekends, cash payments, or Harley Davidson goods” to prescribe its drugs Aceon, Luvox and AndroGel for uses not approved by the Food and Drug Administration.
Solvay is a Belgian chemical company. Its co-defendant subsidiary, Solvay America, is based in Houston. Another defendant is Solvay Pharmaceuticals, which was a Solvay subsidiary until Abbott Laboratories acquired it in 2009, and spun it off into a new entity called AbbVie Products. Full article »
